Pegylated recombinant canine human uricase
聚乙二醇化重组犬人尿酸酶
Report date: 2025/02/27 16:29:36
Base Information
Drug NamePegylated recombinant canine human uricase
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesChongqing Fujin Biological Medicine Co Ltd
China Registration ClassClass 1 therapeutic biologic in China
Develop Information
Active CompaniesShandong New Time Pharmaceutical Co Ltd
Inactive CompaniesChongqing Fujin Biological Medicine Co Ltd
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A